Study Evaluating Renal Cell Carcinoma Risk Factors

Prospective, Multicenter, Epidemiological Study To Determine The Clinical, Molecular And Genetic Factors Associated To The Prognosis Of Patients With Advanced Renal Cell Carcinoma

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT00927043

Acronym

MICRA

Enrollment

145

Registered

2009-06-24

Start date

2009-05-31

Completion date

2011-09-30

Last updated

2011-11-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Carcinoma, Renal Cell

Brief summary

This is an epidemiological, prospective, multicenter study designed to identify the pre-treatment clinical, molecular and genetic prognostic factors associated with progression free survival in patients naïve to renal cell carcinoma (RCC) treatment.

Detailed description

invitation to volunteer

Interventions

OTHEREpidemiological study according to clinical practice

Epidemiological study according to clinical practice.

Study design

Observational model

COHORT

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

18 Years to No maximum

Healthy volunteers

Inclusion criteria

* Treatment naïve patients with proven advanced RCC will be evaluated. (Except surgery or radiotherapy) * =18 years, any gender. * Patients with advanced Renal Cell Carcinoma and treatment naïve.

Exclusion criteria

* Patients who have already initiated any kind of specific therapy for the treatment of RCC.2. * Patients with other neoplasias different from RCC (current or past).

Design outcomes

Primary

Measure	Time frame
Progression-free survival	12 months

Secondary

Measure	Time frame
Response rate.	12 months
Overall survival.	12 months

Countries

Spain

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026